BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JWJ, Zhu F, Srivastava S, Tsao SK, Khor C, Ho KY, Fock KM, Lim WC, Ang TL, Chow WC, So JBY, Koh CJ, Chua SJ, Wong ASY, Rao J, Lim LG, Ling KL, Chia CK, Ooi CJ, Rajnakova A, Yap WM, Salto-Tellez M, Ho B, Soong R, Chia KS, Teo YY, Teh M, Yeoh KG. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP). Gut 2022;71:854-63. [PMID: 33975867 DOI: 10.1136/gutjnl-2021-324057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Brown JW. Gut check: can other microbes or communities phenocopy H. pylori's early gastric pathology? Gut 2022;71:1241-2. [PMID: 34556521 DOI: 10.1136/gutjnl-2021-325749] [Reference Citation Analysis]
2 Wang Y, Xu Y, Zang Z, Wu L, Li Z. Panoramic Manifold Projection (Panoramap) for Single-Cell Data Dimensionality Reduction and Visualization. IJMS 2022;23:7775. [DOI: 10.3390/ijms23147775] [Reference Citation Analysis]
3 Arai J, Niikura R, Hayakawa Y, Aoki T, Yamada A, Kawai T, Fujishiro M. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer. Gut 2022;71:1043-4. [PMID: 34344784 DOI: 10.1136/gutjnl-2021-325551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Arai J, Aoki T, Hayakawa Y, Fujishiro M. Response. Gastrointest Endosc 2022;96:166. [PMID: 35715119 DOI: 10.1016/j.gie.2022.03.027] [Reference Citation Analysis]
5 Du S, Yang Y, Fang S, Guo S, Xu C, Zhang P, Wei W. Gastric Cancer Risk of Intestinal Metaplasia Subtypes: A Systematic Review and Meta-Analysis of Cohort Studies. Clin Transl Gastroenterol 2021;12:e00402. [PMID: 34597278 DOI: 10.14309/ctg.0000000000000402] [Reference Citation Analysis]
6 Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O'Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut 2022:gutjnl-2022-327745. [PMID: 35944925 DOI: 10.1136/gutjnl-2022-327745] [Reference Citation Analysis]
7 Zeng Y, Jin RU. Molecular Pathogenesis, Targeted Therapies, and Future Perspectives for Gastric Cancer. Semin Cancer Biol 2021:S1044-579X(21)00297-2. [PMID: 34933124 DOI: 10.1016/j.semcancer.2021.12.004] [Reference Citation Analysis]